Management of hypertension in high-risk ethnic minority with heart failure

International Journal of Hypertension

Volumn 2011, Issue , 2011, Pages

  Demede, M ^a   Pandey, A ^a   Innasimuthu, L ^a   Jean Louis, G ^a   McFarlane, S I ^a   Ogedegbe, G ^b  

^a Downstate Health Sciences University   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; ALDOSTERONE SYNTHASE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHLORTALIDONE; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; EPLERENONE; GUANINE NUCLEOTIDE BINDING PROTEIN; HYDRALAZINE PLUS ISOSORBIDE DINITRATE; HYDROCHLOROTHIAZIDE; NITRIC OXIDE; PLACEBO; PRAZOSIN; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT; VASODILATOR AGENT;

AFRICAN AMERICAN; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL (TOPIC); DIABETES MELLITUS; ELECTROLYTE DISTURBANCE; ENDOTHELIAL DYSFUNCTION; HEART FAILURE; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HIGH RISK POPULATION; HUMAN; HYPERTENSION; HYPERURICEMIA; KINESIOTHERAPY; LIFESTYLE MODIFICATION; LOW DRUG DOSE; PATHOPHYSIOLOGY; PATIENT COUNSELING; PATIENT EDUCATION; POSITIVE END EXPIRATORY PRESSURE; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; RACE DIFFERENCE; REVIEW; RISK FACTOR; RISK REDUCTION; SLEEP DISORDERED BREATHING; SODIUM RESTRICTION; TREATMENT OUTCOME; WEIGHT REDUCTION;

EID: 84868295232     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.4061/2011/417594     Document Type: Review

References (88)

1. Kearney P. M., Whelton M., Reynolds K., Muntner P., Whelton P. K., He J., Global burden of hypertension: analysis of worldwide data. Lancet 2005 365 9455 217 223 2-s2.0-12344282783 10.1016/S0140-6736(05)17741-1 (Pubitemid 40138015)
2. Ezzati M., Lopez A. D., Rodgers A., Vander H. S., Murray C. J. L., Selected major risk factors and global and regional burden of disease. Lancet 2002 360 9343 1347 1360 2-s2.0-0037010474 10.1016/S0140-6736(02)11403-6 (Pubitemid 35341298)
3. Vital signs: prevalence, treatment, and control of hypertensionUnited States, 19992002 and 20052008. Morbidity and Mortality Weekly Report 2011 60 4 103 108
4. Roger V. L., Go A. S., Lloyd-Jones D. M., Adams R. J., Berry J. D., Brown T. M., Carnethon M. R., Dai S., De Simone G., Ford E. S., Fox C. S., Fullerton H. J., Gillespie C., Greenlund K. J., Hailpern S. M., Heit J. A., Michael Ho P., Howard V. J., Kissela B. M., Kittner S. J., Lackland D. T., Lichtman J. H., Lisabeth L. D., Makuc D. M., Marcus G. M., Marelli A., Matchar D. B., McDermott M. M., Meigs J. B., Moy C. S., Mozaffarian D., Mussolino M. E., Nichol G., Paynter N. P., Rosamond W. D., Sorlie P. D., Stafford R. S., Turan T. N., Turner M. B., Wong N. D., Wylie-Rosett J., Heart disease and stroke statistics-2011 update: a report from the American Heart Association. Circulation 2011 123 4 e18 e19 10.1161/CIR.0b013e3182009701
5. Heidenreich P. A., Trogdon J. G., Khavjou O. A., Butler J., Dracup K., Ezekowitz M. D., Finkelstein E. A., Hong Y., Johnston S. C., Khera A., Lloyd-Jones D. M., Nelson S. A., Nichol G., Orenstein D., Wilson P. W. F., Woo Y. J., Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation 2011 123 8 933 944 10.1161/CIR.0b013e31820a55f5
6. Levy D., Larson M. G., Vasan R. S., Kannel W. B., Ho K. K. L., The progression from hypertension to congestive heart failure. Journal of the American Medical Association 1996 275 20 1557 1562 2-s2.0-0030002580 10.1001/jama.275.20.1557 (Pubitemid 26154241)
7. Jonovich M. R., Bisognano J. D., Management of hypertension in chronic heart failure. Manual of Heart Failure Management 2009 1 15
8. Kannel W. B., Castelli W. P., McNamara P. M., McKee P. A., Feinleib M., Role of blood pressure in the development of congestive heart failure. The Framingham study. New England Journal of Medicine 1972 287 16 781 787 2-s2.0-0015516389
9. Stewart S., MacIntyre K., Hole D. J., Capewell S., McMurray J. J. V., More malignant than cancer? Five-year survival following a first admission for heart failure. European Journal of Heart Failure 2001 3 3 315 322 2-s2.0-0034820506 10.1016/S1388-9842(00)00141-0 (Pubitemid 32895839)
10. Franciosa J. A., Ferdinand K. C., Yancy C. W., Treatment of heart failure in African Americans: a consensus statement. Congestive Heart Failure 2010 16 1 27 38 2-s2.0-74549198181 10.1111/j.1751-7133.2009.00118.x
11. Cushman W. C., Ford C. E., charles.e.ford@uth.tmc.edu Einhorn P. T., Wright Jr. J. T., Preston R. A., Davis B. R., Basile J. N., Whelton P. K., Weiss R. J., Bastien A., Courtney D. L., Hamilton B. P., Kirchner K., Louis G. T., Retta T. M., Vidt D. G., Blood pressure control by drug group in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). Journal of Clinical Hypertension 2008 10 10 751 760 10.1111/j.1751-7176.2008.00015.x
12. Cushman W. C., William.Cushman@med.va.gov Ford C. E., Cutler J. A., Margolis K. L., Davis B. R., Grimm R. H., Black H. R., Hamilton B. P., Holland J., Nwachuku C., Papademetriou V., Probstfield J., Wright Jr. J. T., Alderman M. H., Weiss R. J., Piller L., Bettencourt J., Walsh S. M., Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attact trial (ALLHAT). Journal of Clinical Hypertension 2002 4 6 393 404 (Pubitemid 35469393)
13. Chobanian A. V., Bakris G. L., Black H. R., Cushman W. C., Green L. A., Izzo J. L., Jones D. W., Materson B. J., Oparil S., Wright J. T., Roccella E. J., The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: The JNC 7 report. Journal of the American Medical Association 2003 289 19 2560 2572 2-s2.0-0038460302 10.1001/jama.289.19.2560 (Pubitemid 37430158)
14. Yancy C. W., Heart failure in African Americans. American Journal of Cardiology 2005 96 7 3i 12i 2-s2.0-26444562493 10.1016/j.amjcard.2005.07.028 (Pubitemid 41437919)
15. Okin P. M., Kjeldsen S. E., Dahlof B., Devereux R. B., Racial differences in incident heart failure during antihypertensive therapy. Circadian Cardiovascular Quality Outcomes 2011 4 2 157 164
16. Evangelista L. S., Dracup K., Doering L. V., Racial differences in treatment-seeking delays among heart failure patients. Journal of Cardiac Failure 2002 8 6 381 386 2-s2.0-0036932911 10.1054/jcaf.2002.129234 (Pubitemid 36055739)
17. Vita J. A., Nitric oxide and vascular reactivity in African American patients with hypertension. Journal of Cardiac Failure 2003 9 5 S199 S204 2-s2.0-2142858293 10.1054/S1071-9164(03)00588-8 (Pubitemid 41096360)
18. Jessup M., Abraham W. T., Casey D. E., Feldman A. M., Francis G. S., Ganiats T. G., Konstam M. A., Mancini D. M., Rahko P. S., Silver M. A., Stevenson L. W., Yancy C. W., 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009 119 14 1977 2016 2-s2.0-65549154913 10.1161/CIRCULATIONAHA.109.192064
19. Loscalzo J., Welch G., Nitric oxide and its role in the cardiovascular system. Progress in Cardiovascular Diseases 1995 38 2 87 104 2-s2.0-0029091366 10.1016/S0033-0620(05)80001-5
20. Weir M. R., tchipp@renal.ab.umd.edu Gray J. M., Paster R., Saunders E., Differing mechanisms of action of angiotensin-converting enzyme inhibition in black and white hypertensive patients. Hypertension 1995 26 1 124 130
21. Cardillo C., Kilcoyne C. M., Cannon R. O., Panza J. A., Racial differences in nitric oxide-mediated vasodilator response to mental stress in the forearm circulation. Hypertension 1998 31 6 1235 1239 2-s2.0-0031838355 (Pubitemid 28248821)
22. Small K. M., Wagoner L. E., Levin A. M., Kardia S. L. R., Liggett S. B., Synergistic polymorphisms of β-and α -adrenergic receptors and the risk of congestive heart failure. New England Journal of Medicine 2002 347 15 1135 1142 2-s2.0-0037057235 10.1056/NEJMoa020803
23. Hunt S. A., Abraham W. T., Chin M. H., Feldman A. M., Francis G. S., Ganiats T. G., Jessup M., Konstam M. A., Mancini D. M., Michl K., Oates J. A., Rahko P. S., Silver M. A., Stevenson L. W., Yancy C. W., Antman E. M., Smith Jr. S. C., Adams C. D., Anderson J. L., Faxon D. P., Fuster V., Halperin J. L., Hiratzka L. F., Jacobs A. K., Nishimura R., Ornato J. P., Page R. L., Riegel B., ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure): developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation. 2005 112 12 e154 e235
24. Probstfield J. L., Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). Journal of the American Medical Association 1991 265 24 3255 3264 10.1001/jama.265.24.3255
25. Effects of treatment on morbidity in hypertension. Results in patients with diastolic blood pressures averaging 115 through 129 mm Hg. Journal of the American Medical Association 1967 202 11 1028 1034
26. Effects of treatment on morbidity in hypertensionII. Results in patients with diastolic blood pressure averaging 90 through 114 mm Hg. Journal of the American Medical Association 1970 213 7 1143 1152
27. Dahlof B., Lindholm L. H., Hansson L., Schersten B., Ekbom T., Wester P. O., Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991 338 8778 1281 1285 2-s2.0-0025942936 10.1016/0140-6736(91)92589-T
28. Cohn J. N., Archibald D. G., Ziesche S., Effect of vasodilator therapy on mortality in chronic congestive heart failure: results of a Veterans Administration Cooperative Study. New England Journal of Medicine 1986 314 24 1547 1552 (Pubitemid 16114684)
29. Swedberg K., Idanpaan-Heikkila U., Remes J., Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). New England Journal of Medicine 1987 316 23 1429 1435 (Pubitemid 17079089)
30. Yusuf S., Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. New England Journal of Medicine 1991 325 5 293 302 2-s2.0-0025913812
31. Packer M., Bristow M. R., Cohn J. N., Colucci W. S., Fowler M. B., Gilbert E. M., Shusterman N. H., The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. New England Journal of Medicine 1996 334 21 1349 1355 10.1056/NEJM199605233342101 (Pubitemid 26152713)
32. Hjalmarson A., Goldstein S., Fagerberg B., Wedel H., Waagstein F., Kjekshus J., Wikstrand J., Westergren G., Thimell M., El Allaf D., Vitovec J., Aldershvile J., Halinen M., Dietz R., Neuhaus K. L., Janosi A., Thorgeirsson G., Dunselman P., Gullestad L., Kuch J., Herlitz J., Rickenbacher P., Ball S., Gottlieb S., Deedwania P., Vandenhoven G., Novakova I., Danker S., Lundstrom M., Meyer-Sabellek W., Balla I., Sveinsdottir M., Dorhout B., Hildebrandt A., Szczurko I., Larsson C., Bucher E., Scott E., Dwyer D., Julian D. G., DeMets D. L., Chatterjee K., Feyzi J., Lehto S., Karpati P., Motz W., Samuelsson O., Viersma J. W., Andersson B., Berthe C., Boutefeu J. M., Boxho G., Decroly P., Derbaudrenghien J. P., Pirlet J., Henry P., Heyndrickx G., Missault L., Nannan M., Timmermans P., Vachiery J. L., Van Mieghem W., Vandenbossche J. L., Dvorak K., Herold M., Hradec J., Kana A., Petr P., Rybka J., Smid J., Svitil P., Toman J., Agner E., Amtorp O., Egstrup K., Eliasen P., Gotzsche C. O., Hildebrandt P., Johannesen A., Kaiser-Nielsen P., Nielsen H., Nielsen P. E., Pedersen F., Rokkedal Nielsen J., Skagen K., Honkanen T., Hussi E., Juvonen J., Jaaskelainen H., Rinne J., Salonen T., Andersen D., Berwing H., Bethge., Beythien., Bischoff., Bundschu., Daniel., Darius., Effect of metoprolol CR/XL in chronic heart failure: metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF). Lancet 1999 353 9169 2001 2007 2-s2.0-0033549290 10.1016/S0140-6736(99)04440-2 (Pubitemid 29271744)
33. Dargie H. J., Lechat P., The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999 353 9146 9 13 2-s2.0-0033514046 10.1016/S0140-6736(98)11181-9 (Pubitemid 29037695)
34. Pitt B., Zannad F., Remme W. J., Cody R., Castaigne A., Perez A., The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. The New England Journal of Medicine 1999 341 10 709 717 (Pubitemid 29407370)
35. He J., Whelton P. K., Appel L. J., Charleston J., Klag M. J., Long-term effects of weight loss and dietary sodium reduction on incidence of hypertension. Hypertension 2000 35 2 544 549 2-s2.0-0033982397 (Pubitemid 30108146)
36. U.S. Department of Agriculture and U.S. Department of Health and Human Services, Dietary Guidelines for Americans, 2010 2011 7th Washington, DC, USA U.S. Government Printing Office
37. Gao S. K., Fitzpatrick A. L., Psaty B., Jiang R., Post W., Cutler J., Maciejewski M. L., Suboptimal nutritional intake for hypertension control in 4 ethnic groups. Archives of Internal Medicine 2009 169 7 702 707 2-s2.0-65249118936 10.1001/archinternmed.2009.17
38. Sacks F. M., fsacks@hsph.harvard.edu Svetkey L. P., Vollmer W. M., Appel L. J., Bray G. A., Harsha D., Obarzanek E., Conlin P. R., Miller III E. R., Simons-Morton D. G., Karanja N., Lin P.-H., Aickin M., Most-Windhauser M. M., Moore T. J., Proschan M. A., Cutler J. A., Effects on blood pressure of reduced dietary sodium and the dietary approaches to stop hypertension (dash) diet. New England Journal of Medicine 2001 344 1 3 10 10.1056/NEJM200101043440101 (Pubitemid 32064838)
39. Cook N. R., Cutler J. A., Obarzanek E., Buring J. E., Rexrode K. M., Kumanyika S. K., Appel L. J., Whelton P. K., Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). British Medical Journal 2007 334 7599 885 888 2-s2.0-34247863975 10.1136/bmj.39147.604896.55 (Pubitemid 46724330)
40. Appel L. J., lappel@jhmi.edu Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. Journal of the American Medical Association 2003 289 16 2083 2093 10.1001/jama.289.16.2083 (Pubitemid 37430210)
41. Specchia G., De Servi S., Scirè A., Assandri J., Berzuini C., Angoli L., Rovere M. T. L., Cobelli F., Interaction between exercise training and ejection fraction in predicting prognosis after a first myocardial infarction. Circulation 1996 94 5 978 982 2-s2.0-0029811801 (Pubitemid 26292850)
42. Whelton S. P., Chin A., Xin X., He J., Effect of aerobic exercise on blood pressure: a meta-analysis of randomized, controlled trials. Annals of Internal Medicine 2002 136 7 493 503 2-s2.0-0037006994 (Pubitemid 34252283)
43. Scisney-Matlock M., mscisney@umich.edu Bosworth H. B., Giger J. N., Strickland O. L., Van Harrison R., Coverson D., Shah N. R., Dennison C. R., Dunbar-Jacob J. M., Jones L., Ogedegbe G., Batts-Turner M. L., Jamerson K. A., Strategies for implementing and sustaining therapeutic lifestyle changes as part of hypertension management in African Americans. Postgraduate Medicine 2009 121 3 147 159 10.3810/pgm.2009.05.2015
44. Murrock C. J., Gary F. A., A culturally-specific dance intervention to increase functional capacity in African American women. Journal of Cultural Diversity 2008 15 4 168 173 2-s2.0-63449088246
45. National Center for Health Statistics. National Health and Nutrition Examination Survey 2005-2006
46. Mitchell J. E., judith.mitchell@downstate.edu Ferdinand K. C., Watson K. E., Wenger N. K., Watkins L. O., Flack J. M., Gavin III J. R., Reed J. W., Saunders E., Wright Jr. J. T., Treatment of heart failure in African Americansa call to action. Journal of the National Medical Association 2011 103 2 86 98
47. Taylor A. L., Ziesche S., Yancy C., Carson P., D'Agostino R., Ferdinand K., Taylor M., Adams K., Sabolinski M., Worcel M., Conn J. N., Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. New England Journal of Medicine 2004 351 20 2049 2141 2-s2.0-19644400578 10.1056/NEJMoa042934 (Pubitemid 39482498)
48. Psaty B. M., Smith N. L., Siscovick D. S., Koepsell T. D., Weiss N. S., Heckbert S. R., Lemaitre R. N., Wagner E. H., Furberg C. D., Health outcomes associated with antihypertensive therapies used as first-line agents: a systematic review and meta-analysis. Journal of the American Medical Association 1997 277 9 739 745 2-s2.0-0031044480 (Pubitemid 27106227)
49. Furberg C. D., Wright J. T., Davis B. R., Cutler J. A., Alderman M., Black H., Cushman W., Grimm R., Haywood L. J., Leenen F., Oparil S., Probstfield J., Whelton P., Nwachuku C., Gordon D., Proschan M., Einhom P., Ford C. E., Piller L. B., Dunn I. K., Goff D., Pressel S., Bettencourt J., DeLeon B., Simpson L. M., Blanton J., Geraci T., Walsh S. M., Nelson C., Rahman M., Juratovac A., Pospisil R., Carroll L., Sullivan S., Russo J., Barone G., Christian R., Feldman S., Lucente T., Calhoun D., Jenkins K., McDowell P., Johnson J., Kingry C., Alzate J., Margolis K. L., Holland-Klemme L. A., Jaeger B., Williamson J., Louis G., Ragusa P., Williard A., Ferguson R. L. S., Tanner J., Eckfeldt J., Crow R., Pelosi J., Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). Journal of the American Medical Association 2002 288 23 2981 2997 2-s2.0-0344373794 10.1001/jama.288.23.2981 (Pubitemid 35471160)
50. Messerli F. H., fmesserl@chpnet.org Makani H., Benjo A., Romero J., Alviar C., Bangalore S., Antihypertensive efficacy of hydrochlorothiazide as evaluated by ambulatory blood pressure monitoring: a meta-analysis of randomized trials. Journal of the American College of Cardiology 2011 57 5 590 600 10.1016/j.jacc.2010.07.053
51. McMurray J., Östergren J., Pfeffer M., Swedberg K., Granger C., Yusuf S., Held P., Michelson E., Olofsson B., Clinical features and contemporary management of patients with low and preserved ejection fraction heart failure: baseline characteristics of patients in the Candesartan in Heart failureassessment of Reduction in Mortality and morbidity (CHARM) programme. European Journal of Heart Failure 2003 5 3 261 270 2-s2.0-0042890654 10.1016/S1388-9842(03)00052-7 (Pubitemid 37011854)
52. Lindholm L. H., Carlberg B., Samuelsson O., Should β blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet 2005 366 9496 1545 1553 2-s2.0-27544463207 10.1016/S0140-6736(05)67573-3 (Pubitemid 41540112)
53. Pitt B., Remme W., Zannad F., Neaton J., Martinez F., Roniker B., Bittman R., Hurley S., Kleiman J., Gatlin M., Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. New England Journal of Medicine 2003 348 14 1309 1321 2-s2.0-0037417252 10.1056/NEJMoa030207 (Pubitemid 36384098)
54. Loeb H. S., Johnson G., Henrick A., Smith R., Wilson J., Cremo R., Cohn J. N., Effect of enalapril, hydralazine plus isosorbide dinitrate, and prazosin on hospitalization in patients with chronic congestive heart failure. Circulation 1993 87 6, supplement 1 VI78 VI87 (Pubitemid 23164226)
55. McNamara D. M., Tam S. W., Sabolinski M. L., Tobelmann P., Janosko K., Taylor A. L., Cohn J. N., Feldman A. M., Worcel M., Aldosterone synthase promoter polymorphism predicts outcome in African Americans with heart failure. Results from the A-HeFT trial. Journal of the American College of Cardiology 2006 48 6 1277 1282 2-s2.0-33748428075 10.1016/j.jacc.2006.07.030 (Pubitemid 44345151)
56. Flack J. M., jflack@med.wayne.edu Sica D. A., Bakris G., Brown A. L., Ferdinand K. C., Grimm R. H., Hall W. D., Jones W. E., Kountz D. S., Lea J. P., Nasser S., Nesbitt S. D., Saunders E., Scisney-Matlock M., Jamerson K. A., Management of high blood pressure in blacks: an update of the International Society on Hypertension in Blacks consensus statement. Hypertension 2010 56 5 780 800 10.1161/HYPERTENSIONAHA.110.152892
57. Ferdinand K. C., Armani A. M., The management of hypertension in African Americans. Critical Pathways in Cardiology 2007 6 2 67 71 2-s2.0-34249930488 10.1097/HPC.0b013e318053da59 (Pubitemid 46878235)
58. Floras J. S., Bradley T. D., Treating obstructive sleep apnea: is there more to the story than 2 millimeters of mercury? Hypertension 2007 50 2 289 291 2-s2.0-34547638955 10.1161/HYPERTENSIONAHA.107.092106 (Pubitemid 47205773)
59. Fletcher E. C., The relationship between systemic hypertension and obstructive sleep apnea: facts and theory. American Journal of Medicine 1995 98 2 118 128 2-s2.0-0028895622 10.1016/S0002-9343(99)80395-7
60. Ferrier K., Campbell A., Yee B., Richards M., O'Meeghan T., Weatherall M., Neill A., Sleep-disordered breathing occurs frequently in stable outpatients with congestive heart failure. Chest 2005 128 4 2116 2122 2-s2.0-27144478272 10.1378/chest.128.4.2116 (Pubitemid 41507549)
61. Redline S., Tishler P. V., Hans M. G., Tosteson T. D., Strohl K. P., Spry K., Racial differences in sleep-disordered breathing in African-Americans and Caucasians. American Journal of Respiratory and Critical Care Medicine 1997 155 1 186 192 2-s2.0-0031034046 (Pubitemid 27053162)
62. Young T., Peppard P., Palta M., Hla K. M., Finn L., Morgan B., Skatrud J., Population-based study of sleep-disordered breathing as a risk factor for hypertension. Archives of Internal Medicine 1997 157 15 1746 1752 2-s2.0-0030742786 (Pubitemid 27327411)
63. Godoy J., Mellado P., Tapia J., Santín J., Obstructive Sleep Apnea as an independent stroke risk factor: possible mechanisms. Current Molecular Medicine 2009 9 2 203 209 2-s2.0-65649139083 10.2174/156652409787581556
64. Friedman O., Logan A. G., alogan@mtsinai.on.ca The price of obstructive sleep apnea-hypopnea: hypertension and other ill effects. American Journal of Hypertension 2009 22 5 474 483 10.1038/ajh.2009.43
65. Lavie P., Herer P., Hoffstein V., Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. British Medical Journal 2000 320 7233 479 482 2-s2.0-0034685268 (Pubitemid 30173118)
66. Peppard P. E., Young T., Palta M., Skatrud J., Prospective study of the association between sleep-disordered breathing and hypertension. New England Journal of Medicine 2000 342 19 1378 1384 2-s2.0-0034636477 10.1056/ NEJM200005113421901 (Pubitemid 30262394)
67. Shahar E., Whitney C. W., Redline S., Lee E. T., Newman A. B., Javler F., George N., O'Connor T., Boland L. L., Schwartz J. E., Samet J. M., Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the sleep heart health study. American Journal of Respiratory and Critical Care Medicine 2001 163 1 19 25 (Pubitemid 32095247)
68. Bradley T. D., douglas.bradley@utoronto.ca Floras J. S., Obstructive sleep apnoea and its cardiovascular consequences. The Lancet 2009 373 9657 82 93 10.1016/S0140-6736(08)61622-0
69. Alchanatis M., Paradellis G., Pini H., Tourkohoriti G., Jordanoglou J., Left ventricular function in patients with obstructive sleep apnoea syndrome before and after treatment with nasal continuous positive airway pressure. Respiration 2000 67 4 367 371 (Pubitemid 30665996)
70. Laaban J.-P., Pascal-Sebaoun S., Bloch E., Orvoën-Frija E., Oppert J.-M., Huchon G., Left ventricular systolic dysfunction in patients with obstructive sleep apnea syndrome. Chest 2002 122 4 1133 1138 10.1378/chest.122.4.1133 (Pubitemid 35339521)
71. Arias M. A., García-Río F., Alonso-Fernández A., Mediano O., Martínez I., Villamor J., Obstructive sleep apnea syndrome affects left ventricular diastolic function: effects of nasal continuous positive airway pressure in men. Circulation 2005 112 3 375 383 2-s2.0-22544482105 10.1161/CIRCULATIONAHA.104.501841 (Pubitemid 41022078)
72. Chan J., Sanderson J., Chan W., Lai C., Choy D., Ho A., Leung R., Prevalence of sleep-disordered breathing in diastolic heart failure. Chest 1997 111 6 1488 1493 2-s2.0-0030919824 (Pubitemid 27260070)
73. Hyer R., Obstructive Sleep Apnea Linked to Vulnerable Vessel Plaque on CT. Internal Medicine News 2011 Elsevier
74. Mansfield D. R., Gollogly N. C., Kaye D. M., Richardson M., Bergin P., Naughton M. T., Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. American Journal of Respiratory and Critical Care Medicine 2004 169 3 361 366 2-s2.0-1642455888 (Pubitemid 38134815)
75. Giles T. L., Lasserson T. J., Smith B. J., White J., Wright J., Cates C. J., Continuous positive airways pressure for obstructive sleep apnoea in adults (Review). Cochrane Database of Systematic Reviews 2006 3 2-s2.0-37649026587 10.1002/14651858.CD001106.pub3 CD001106
76. Magalang U. J., Richards K., McCarthy B., Fathala A., Khan M., Parinandi N., Raman S. V., raman.1@osu.edu Continuous positive airway pressure therapy reduces right ventricular volume in patients with obstructive sleep apnea: a cardiovascular magnetic resonance study. Journal of Clinical Sleep Medicine 2009 5 2 110 114
77. Kaneko Y., Floras J. S., Usui K., Plante J., Tkacova R., Kubo T., Ando S. I., Bradley T. D., Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. New England Journal of Medicine 2003 348 13 1233 1241 2-s2.0-0037468692 (Pubitemid 36359299)
78. Pepperell J. C. T., Ramdassingh-Dow S., Crosthwaite N., Mullins R., Jenkinson C., Stradling J. R., Davies R. J.O., robert.davies@ndm.ox.ac.uk Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial. Lancet 2002 359 9302 204 210 10.1016/S0140-6736(02)07445-7 (Pubitemid 34113817)
79. Dimsdale J. E., Loredo J. S., Profant J., Effect of continuous positive airway pressure on blood pressure: a placebo trial. Hypertension 2000 35 1 I 144 147 2-s2.0-0033978496 (Pubitemid 30054251)
80. Faccenda J. F., jff@srv1.med.ed.ac.uk Mackay T. W., Boon N. A., Douglas N. J., Randomized placebo-controlled trial of continuous positive airway pressure on blood pressure in the sleep apnea-hypopnea syndrome. American Journal of Respiratory and Critical Care Medicine 2001 163 2 344 348 (Pubitemid 32158510)
81. Becker H. F., Jerrentrup A., Ploch T., Grote L., Penzel T., Sullivan C. E., Peter J. H., Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 2003 107 1 68 73 2-s2.0-0037422591 10.1161/01.CIR.0000042706.47107.7A (Pubitemid 36070935)
82. Campos-Rodriguez F., Grilo-Reina A., Perez-Ronchel J., Merino-Sanchez M., Gonzalez-Benitez M. A., Beltran-Robles M., Almeida-Gonzalez C., Effect of continuous positive airway pressure on ambulatory BP in patients with sleep apnea and hypertension: a placebo-controlled trial. Chest 2006 129 6 1459 1467 2-s2.0-33745120484 10.1378/chest.129.6.1459 (Pubitemid 43894973)
83. Campos-Rodriguez F., Perez-Ronchel J., Grilo-Reina A., Lima-Alvarez J., Benitez M. A., Almeida-Gonzalez C., Long-term effect of continuous positive airway pressure on BP in patients with hypertension and sleep apnea. Chest 2007 132 6 1847 1852 2-s2.0-37549061417 10.1378/chest.07-1478
84. Durán-Cantolla J., Aizpuru F., Montserrat J. M., Ballester E., Terán-Santos J., Aguirregomoscorta J. I., Gonzalez M., Lloberes P., Masa J. F., De La Peña M., Carrizo S., Mayos M., Barbé F., Spanish Sleep and Breathing Group, Continuous positive airway pressure as treatment for systemic hypertension in people with obstructive sleep apnoea: randomised controlled trial. British Medical Journal 2010 341 c5991
85. Egea C. J., Aizpuru F., Pinto J. A., Ayuela J. M., Ballester E., Zamarrón C., Sojo A., Montserrat J. M., Barbe F., Cortés J., Cardiac function after CPAP therapy in patients with chronic heart failure and sleep apnea: a multicenter study. Sleep Medicine 2008 9 6 660 666 2-s2.0-48449093656 10.1016/j.sleep.2007.06.018
86. Becker D. M., Tuggle M. B., Prentice M. F., Building a gateway to promote cardiovascular health research in African-American communities: lessons and findings from the field. American Journal of the Medical Sciences 2001 322 5 288 293 2-s2.0-0035160187 (Pubitemid 33055225)
87. Adams K. F., Lindenfeld J., Arnold J. M. O., Baker D. W., Barnard D. H., Baughman K. L., Boehmer J. P., Deedwania P., Dunbar S. B., Elkayam U., Gheorghiade M., Howlett J. G., Konstam M. A., Kronenberg M. W., Massie B. M., Mehra M. R., Miller A. B., Moser D. K., Patterson J. H., Rodeheffer R. J., Sackner-Bernstein J., Silver M. A., Starling R. C., Stevenson L. W., Wagoner L. E., Executive summary: HFSA 2006 comprehensive heart failure practice guideline. Journal of Cardiac Failure 2006 12 1 10 38 2-s2.0-33144483487 10.1016/j.cardfail.2005.12.001 (Pubitemid 43267749)
88. Levy D., Kenchaiah S., Larson M. G., Benjamin E. J., Kupka M. J., Ho K. K. L., Murabito J. M., Vasan R. S., Rocha E., Long-term trends in the incidence of and survival with heart failure. Revista Portuguesa de Cardiologia 2002 21 11 1377 1378 2-s2.0-0036869432 (Pubitemid 36041825)